schliessen

Filtern

 

Bibliotheken

2.

Human artificial chromosome (HAC) vector with a conditional centromere for correction of genetic deficiencies in human cells
by Kim , Jung-Hyun 2011

Proceedings of the National Academy of Sciences of the United States of America, 2011, Vol.108(50), pp.20048-20053

2011
8.

Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors
by Yeh, Tammie

Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, Feb 15, 2017, Vol.23(4), pp.1025-1035

15.

Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System
by Veldman-Jones, Margaret H

Clinical cancer research : an official journal of the American Association for Cancer Research, 15 May 2015, Vol.21(10), pp.2367-78

16.

Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors
by Sharpe, Alan

Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, Mar 15, 2017, Vol.23(6), pp.1471-1480

17.

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer.
by Dupont Jensen, Jeanette

Clinical cancer research : an official journal of the American Association for Cancer Research, February 15, 2011, Vol.17(4), pp.667-677

18.

Is target validation all we need?
by Frigault, Melanie M.

Current Opinion in Pharmacology, August, 2014, Vol.17, p.81(6)

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 551 Hits